Tang CHA, Lee AC, Chang S, Xu Q, Shao A, Lo Y, Spalek WT, Pinilla-Ibarz JA, Del Valle JR, and Hu CCA. 2021. STING regulates BCR signaling in normal and malignant B cells. Cell. Mol. Immunol. Apr.; 18(4): 1016-1031.

Shao A, Xu Q, Spalek WT, Cain CF, Kang CW, Tang CHA, Del Valle JR, and Hu CCA. 2020. Development of tumor-specific IRE-1 inhibitors for B cell cancer therapy. Mol. Cancer Ther. Dec.; 19(12): 2432-2444.

Shao A, Kang CW, Tang CHA, Cain C, Xu Q, Phoumyvong C, Del Valle JR, and Hu CCA. 2019. Structural tailoring of a novel fluorescent IRE-1 RNase inhibitor to precisely control its activity. J. Med. Chem. Jun. 13; 62(11): 5404-5413.

Tang CHA, Chang S, Paton AW, Paton JC, Gabrilovich DI, Ploegh HL, Del Valle JR, and Hu CCA. 2018. Phosphorylation of IRE1 at S729 regulates RIDD in B cells and antibody production after immunization. J. Cell Biol. May. 7; 217(5): 1739-1755.

Tang CHA, Zundell JA, Ranatunga S, Lin C, Nefedova Y, Del Valle JR, and Hu CCA. 2016. Agonist-mediated activation of STING induces apoptosis in malignant B cells. Cancer Res. Apr. 15; 76(8): 2137-2152.

Tang CHA, Ranatunga S, Kriss CL, Cubitt CL, Tao J, Pinilla-Ibarz JA, Del Valle JR, and Hu CCA. 2014. Inhibition of ER stress-associated IRE-1/XBP-1 pathway reduces leukemic cell survival. J. Clin. Invest. Jun. 2; 124(6): 2585-2598.

Kriss CL, Pinilla-Ibarz JA, Mailloux AW, Powers JJ, Tang CHA, Kang CW, Zanesi N, Epling-Burnette PK, Sotomayor EM, Croce CM, Del Valle JR, and Hu CCA. 2012. Overexpression of TCL1 activates the endoplasmic reticulum stress response: a novel mechanism of leukemic progression in mice. Blood. Aug. 2; 120(5): 1027-1038.